Grant: CIHR Fellowship
Direct Payment
$150,000.00
Exome Sequencing to Discover Novel Genetic Causes of High or Low High-Density Lipoprotein Cholesterol
FY 2010-11
Summary
Higher levels of plasma high-density cholesterol (HDL-C) correlate with lower risk for
cardiovascular disease (CVD). Individuals treated to a low level of plasma low-density
lipoprotein cholesterol continue to suffer recurrent CVD events at a high rate and among these individuals, plasma HDL-C is a predictor of recurrent CVD events. There is a major unmet need for therapies that raise HDL-C and lower CVD risk.
We will perform exome sequencing to uncover the genetic causes of mendelian families with low or high HDL-C and then perform targeted resequencing of population-based cohorts to identify rare genetic variants of sufficient effect size and frequency at the population level (called Goldilocks alleles). This approach effectively takes advantage of the complementary strengths of Mendelian and population-based genetics. Mendelian diseases in rare families can inform about genes that when altered in people will have large phenotypic effects. However, with genes for monogenic disorders, one often needs to prove that the observation holds beyond a single family. In this regard, identifying Goldilocks alleles are well-suited for gaining insights into the role of genetic variants at a population level.
Department
Program
CIHR Fellowship
Recipient
Location
Massachusetts, United States of America
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
214583
Name
Do Ron
Region
Massachusetts
Country
United States of America
Orgtype
Research Institution
Instname2
Genetics
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Exome Sequencing to Discover Novel Genetic Causes of High or Low High-Density Lipoprotein Cholesterol
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Cardiovascular Genetics; Exome Sequencing; Genetic Association Studies; Mendelian Lipid Disorders
Abstract
Higher levels of plasma high-density cholesterol (HDL-C) correlate with lower risk for
cardiovascular disease (CVD). Individuals treated to a low level of plasma low-density
lipoprotein cholesterol continue to suffer recurrent CVD events at a high rate and among these individuals, plasma HDL-C is a predictor of recurrent CVD events. There is a major unmet need for therapies that raise HDL-C and lower CVD risk.
We will perform exome sequencing to uncover the genetic causes of mendelian families with low or high HDL-C and then perform targeted resequencing of population-based cohorts to identify rare genetic variants of sufficient effect size and frequency at the population level (called Goldilocks alleles). This approach effectively takes advantage of the complementary strengths of Mendelian and population-based genetics. Mendelian diseases in rare families can inform about genes that when altered in people will have large phenotypic effects. However, with genes for monogenic disorders, one often needs to prove that the observation holds beyond a single family. In this regard, identifying Goldilocks alleles are well-suited for gaining insights into the role of genetic variants at a population level.
Competitiondate
201010
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Do, Ron
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~